Recent Antiphospholipid Syndrome News:

 

• Pathophysiology of Primary Budd-Chiari Syndrome: A Narrative Review | Cureus
• SLE in Veterans Increases Maternal Pregnancy Risks – Ophthalmology Advisor
• Catastrophic Antiphospholipid Syndrome Market in 2025 Detailed Study Analysis
• A man is rapidly being brain-damaged because doctors refuse to believe he’s sick – Canary
• The D. Dan and Betty Kahn Health Care Pavilion Floor Maps – Michigan Medicine
• Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates
• EULAR develops first classification criteria for hemochromatosis arthropathy – News-Medical
• Frontiers Participate in “Antiphospholipid syndrome – beyond thrombosis”
• QuidelOrtho Gets FDA 510(k) Clearance for Vitros Troponin Immunoassay Reagents
• Becton Dickinson Gets 510(k) Clearance for BD Cor Enteric Bacteria Panels | 360Dx
• An Unusual Presentation of Antiphospholipid Syndrome With Seizures and Sagittal Sinus …
• Effect of sirolimus on connective tissue disease related refractory thrombocytopenia – Termedia
• Posterior Circulation Stroke in a Patient With May-Thurner Syndrome and Patent Foramen Ovale
• Systematic review substantiates ‘compelling’ potential of CAR T-cell approach in lupus
• Genitourinary Radiology | University of Michigan Health
• Gaps in Contraceptive Counseling Noted in Females Prescribed Teratogenic Drugs – MPR
• Therapeutic plasma exchange in autoimmune diseases: a retrospective study in a tertiary …
• Research progress on bleeding risk assessment models in anticoagulant therapy – Frontiers
• Antiphospholipid Antibodies Linked to Increased Thrombotic Events in SSc
• Study: 96% of patients remain off systemic sclerosis treatment after CAR T-cell therapy
• Large language models ‘substantially’ improved medical trainees’ diagnostic accuracy
• ACR keynote: Finding meaning, ‘sacred moments’ can reduce physician burnout – Healio
• (PDF) Drug-coated balloon angioplasty for catastrophic left main STEMI in a 24-year-old …
• SLE in Veterans Increases Maternal Pregnancy Risks – Rheumatology Advisor
• NETs: a new target for autoimmune disease – Frontiers
• Two-Stage Machine Learning Based Prediction of Thrombophilia Management | medRxiv
• Proposal for the Ischemic Stroke Phenotyping System 2025: ISPS25
• Myocardial Infarction in a Patient With Homozygous Plasminogen Activator Inhibitor-1 (PAI-1 …
• Altered fibrin clot properties and the risk of thromboembolism in women with obstetric …
• ‘Dancing With the Stars’ Carrie Ann Inaba’s Health: Her Sjӧgren’s Syndrome & More
• Drug-coated balloon angioplasty for catastrophic left main STEMI in a 24-year-old with …
• FDA approves Gazyva for lupus nephritis, marking ‘significant advancement’ for patients
• Hydroxychloroquine improves kidney function in patients with lupus nephritis – Healio
• βeta-2 glycoprotein I is a novel regulator of Apolipoprotein E containing HDL particles in females
• Hydroxychloroquine Linked to Improved Pregnancy Outcomes in Women With APS
• Antiphospholipid Syndrome – Journal of Investigative Dermatology
• Research and Advocacy Pays Off in an FDA Action That Will Save Lives
• Common hospice drugs linked to higher death risk in people with dementia
• What is Antiphospholipid Syndrome? | University of Michigan Health
• Patients with systemic sclerosis exhibit three-fold increased risk for cancer – Healio
• Surging Autoimmune Disorder Prevalence Fuels Antiphospholipid Syndrome Treatment Market
• Refractory Antiphospholipid Syndrome With Thoracic Outlet and Superior Vena Cava …
• High-Risk Pregnancy with Solid Pseudopapillary Tumor of the Pancreas C | IJWH
• Carrie Ann Inaba Reveals Health Crisis That Forced Her To Miss Dance Premiere
• Tailoring and teamwork help hospitals reduce wasteful pre-surgery testing – Michigan Medicine
• Primary Antiphospholipid Syndrome Complicated by Recurrent Acute ST-Elevation … – Frontiers
• Correction: Novel advances on pathophysiological mechanisms, clinical manifestations, and …
• Research illuminating ‘powerful regulators of the immune system’ wins Nobel Prize – Healio
• Atypical Presentation of Toxic Shock Syndrome in a Patient With Postpartum Necrotizing Endometritis
• Efficacy and Thrombotic Risk of Thrombopoietin Receptor Agonists for Immune …

Antiphospholipid Syndrome News:

 

• Nine research updates in thrombosis treatment, surveillance and risk prediction.

• Antiphospholipid syndrome. This review summarizes the main knowledge on the clinical and therapeutic aspects of this syndrome.

• Antiphospholipid syndrome: frequency, main causes and risk factors of mortality. Thrombotic complications are the most common cause of death in APS.

• Autoantibodies may be a risk factor for heart attack

• Heart attack: New finding may change the face of treatment

• Hughes syndrome (antiphospholipid syndrome) and the nervous system.

• When autoimmune diseases exert neuro-ophthalmic effects

• Catastrophic antiphospholipid syndrome: The current management approach.

•  2016 review on catastrophic antiphospholipid syndrome.

• Antiphospholipid syndrome in obstetrics.

• Pregnancy and APS: Results Look Encouraging

• The Role of Viral Infections and Vaccines in the Pathogenesis of Antiphospholipid Syndrome

• Anticoagulating patients with high-risk acquired thrombophilias.

• Infectious, Noninfectious Postoperative Complications More Frequent in Patients With SLE

• Catastrophic antiphospholipid syndrome: The current management approach.

• Rapidly progressive coronary artery disease as the first manifestation of antiphospholipid syndrome.  case report
• C-sections raise blood clot risk; protection urged in new recommendation from American College of Obstetricians and Gynecologists. CBS News,
• Myasthenia gravis  is sometimes found in conjunction with antiphospholipid syndrome with: A case report
• Primary antiphospholipid syndrome should be considered as a possible cause of repeated stent thrombosis. Journal of Cardiology Cases.
  
• Good news for prospective mothers with antiphospholipid syndrome? –  Journal of Postgraduate Medicine
• New study suggests that long-term anticoagulation with low molecular weight heparin (LMWH) may be a safe and effective alternative for APS patients who had not responded to warfarin (Coumadin) – Annals of Rhematic Diseases

• Rheumatologist Dr. Doruk Erkan talks about Antiphospholipid Syndrome (APS), the disorder that caused my stroke, in this Q&A with the Hospital for Special Surgery. Read it to learn more about APS. – Dr. Doruk Erkan, Rheumatologist

• Antiphospholipid syndrome plus rheumatic fever: A higher risk factor for stroke? – MD Linx

• Preeclampsia: New Research Reveals Why Preeclampsia More Likely For Some Women – Mattason’s Review

• Antiphospholipid syndrome: endocrinologic manifestations and organ involvement